Antithrombotic therapy in CKD after the 2026 ESC guidelines: clarity versus certainty

Adrian Covic, Alexandru Burlacu

Open source

DOI
10.1093/ndt/gfag218
Published
2026-09-25
Container
Nephrology Dialysis Transplantation
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/ndt/gfag218,
  title = {Antithrombotic therapy in CKD after the 2026 ESC guidelines: clarity versus certainty},
  author = {Adrian Covic and Alexandru Burlacu},
  year = {2026},
  journal = {Nephrology Dialysis Transplantation},
  doi = {10.1093/ndt/gfag218},
  url = {https://doi.org/10.1093/ndt/gfag218}
}

RIS

TY  - JOUR
TI  - Antithrombotic therapy in CKD after the 2026 ESC guidelines: clarity versus certainty
AU  - Adrian Covic
AU  - Alexandru Burlacu
PY  - 2026
JO  - Nephrology Dialysis Transplantation
DO  - 10.1093/ndt/gfag218
UR  - https://doi.org/10.1093/ndt/gfag218
ER  - 

APA

Covic, A., & Burlacu, A. (2026). Antithrombotic therapy in CKD after the 2026 ESC guidelines: clarity versus certainty. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfag218

Source records